Major impact of an early bone marrow checkpoint (day 21) for minimal residual disease in flow cytometry in childhood acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Major impact of an early bone marrow checkpoint (day 21) for minimal residual disease in flow cytometry in childhood acute lymphoblastic leukemia

Published:2015-10-09 Issue:2 Volume:35 Page:237-243
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Eveillard Marion¹,Robillard Nelly¹,Arnoux Isabelle²,Garand Richard¹,Rialland Fanny³,Thomas Caroline³,Strullu Marion³,Michel Gérard⁴,Béné Marie C.¹,Fossat Chantal²,Loosveld Marie²

Affiliation:

1. Hematology Biology; Nantes University Hospital; France

2. Hematology Biology; Timone University Hospital; Marseilles France

3. Oncopediatrics Department; Nantes University Hospital; France

4. Oncopediatrics Department; Timone University Hospital; Marseilles France

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference25 articles.

1. Treatment of acute lymphoblastic leukemia;Pui;New Engl J Med,2006

2. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG);Schultz;Blood,2007

3. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia;Mullighan;New Engl J Med,2009

4. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study;Den Boer;Lancet Oncol,2009

5. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study;Borowitz;Blood,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges;Cancers;2021-09-12

2. Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges;Expert Review of Molecular Diagnostics;2018-08-02

3. Evaluation of minimal residual disease in childhood ALL;International Journal of Laboratory Hematology;2018-05